Cargando…

Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()

BACKGROUND: A fundamental debate in the transition towards universal health coverage concerns whether to establish an explicit health benefits package to which all citizens are entitled, and the level of detail in which to specify that package. At one extreme, the treatments to be funded, and the ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Peter C, Chalkidou, Kalipso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338874/
https://www.ncbi.nlm.nih.gov/pubmed/28212971
http://dx.doi.org/10.1016/j.jval.2016.01.004
_version_ 1782512573793435648
author Smith, Peter C
Chalkidou, Kalipso
author_facet Smith, Peter C
Chalkidou, Kalipso
author_sort Smith, Peter C
collection PubMed
description BACKGROUND: A fundamental debate in the transition towards universal health coverage concerns whether to establish an explicit health benefits package to which all citizens are entitled, and the level of detail in which to specify that package. At one extreme, the treatments to be funded, and the circumstances in which patients qualify for the treatment, might be specified in great detail, and be entirely mandatory. This would make clinicians little more than automata, carrying out prescribed practice. At the other extreme, priorities may be expressed in very broad terms, with no compulsion or other incentives to encourage adherence. OBJECTIVES: The paper examines the arguments for and against setting an explicit benefits package, and discusses the circumstances in which increased detail in specification are most appropriate. METHODS: The English National Health Service is used as a case study, based on institutional history, official documents and research literature. RESULTS: Although the English NHS does not explicitly specify a health benefits package, it is in some respects establishing an ‘intelligent’ package, based on instruments such as an essential medicines list, clinical guidelines, provider payment and performance reporting, which acknowledges gaps in evidence and variations in local resource constraints. CONCLUSIONS: Further moves towards a more explicit specification are likely to yield substantial benefits in most health systems. Considerations in determining the ‘hardness’ of benefits package specification might include the quality of information about the costs and benefits of treatments, the heterogeneity of patient needs and preferences, the financing regime in place, and the nature of supply side constraints.
format Online
Article
Text
id pubmed-5338874
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53388742017-03-13 Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service() Smith, Peter C Chalkidou, Kalipso Value Health Article BACKGROUND: A fundamental debate in the transition towards universal health coverage concerns whether to establish an explicit health benefits package to which all citizens are entitled, and the level of detail in which to specify that package. At one extreme, the treatments to be funded, and the circumstances in which patients qualify for the treatment, might be specified in great detail, and be entirely mandatory. This would make clinicians little more than automata, carrying out prescribed practice. At the other extreme, priorities may be expressed in very broad terms, with no compulsion or other incentives to encourage adherence. OBJECTIVES: The paper examines the arguments for and against setting an explicit benefits package, and discusses the circumstances in which increased detail in specification are most appropriate. METHODS: The English National Health Service is used as a case study, based on institutional history, official documents and research literature. RESULTS: Although the English NHS does not explicitly specify a health benefits package, it is in some respects establishing an ‘intelligent’ package, based on instruments such as an essential medicines list, clinical guidelines, provider payment and performance reporting, which acknowledges gaps in evidence and variations in local resource constraints. CONCLUSIONS: Further moves towards a more explicit specification are likely to yield substantial benefits in most health systems. Considerations in determining the ‘hardness’ of benefits package specification might include the quality of information about the costs and benefits of treatments, the heterogeneity of patient needs and preferences, the financing regime in place, and the nature of supply side constraints. Elsevier 2017-01 /pmc/articles/PMC5338874/ /pubmed/28212971 http://dx.doi.org/10.1016/j.jval.2016.01.004 Text en © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Elsevier Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Smith, Peter C
Chalkidou, Kalipso
Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
title Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
title_full Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
title_fullStr Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
title_full_unstemmed Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
title_short Should Countries Set an Explicit Health Benefits Package? The Case of the English National Health Service()
title_sort should countries set an explicit health benefits package? the case of the english national health service()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338874/
https://www.ncbi.nlm.nih.gov/pubmed/28212971
http://dx.doi.org/10.1016/j.jval.2016.01.004
work_keys_str_mv AT smithpeterc shouldcountriessetanexplicithealthbenefitspackagethecaseoftheenglishnationalhealthservice
AT chalkidoukalipso shouldcountriessetanexplicithealthbenefitspackagethecaseoftheenglishnationalhealthservice